AKT1 and ovarian cancer: In the present study, since we also detected decreased AKT activation in genistein, daidzein and ERB-041 treated ovarian cancer cells, inhibition of AKT signaling might be related to genistein, daidzein and ERB-041 mediated retarded sphere formation.